Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
IVBIY
IVBIY News & Events
-
Add to Watchlist
Trade IVBIY
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
IVBIY News
Innovent Reveals Addition of Seven Innovative Medications, Including New Indication for TYVYT and SYCUME, to China's National Reimbursement Drug List
Dec 07 2025
Yahoo Finance
Innovent signs $11.4 billion collaboration with Takeda for cancer drug development in Japan
Oct 22 2025
SeekingAlpha
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032
Aug 05 2025
Yahoo Finance
/C O R R E C T I O N -- Innovent Biologics/
Jun 16 2025
Yahoo Finance
Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema
May 07 2025
Yahoo Finance
Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies
Apr 30 2025
Yahoo Finance
2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs
Apr 28 2025
Yahoo Finance
Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer
Apr 26 2025
Yahoo Finance
Show More News
IVBIY Events
No data
IVBIY Monitor News
No data
IVBIY Earnings Analysis
No Data
People Also Watch
